Listed

CVS HEALTH Corp: Form 10-K for the period ended Dec 31, 2016

Filed with the SEC on Feb 9, 2017 and accepted by EDGAR at Feb 9, 2017, 16:03 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-10-01 to 2016-12-31$45.97bnus-gaap:Revenues
Cost of revenue12 months2016-01-01 to 2016-12-31$148.67bnus-gaap:CostOfRevenue
Gross profit3 months2016-10-01 to 2016-12-31$7.61bnus-gaap:GrossProfit
Gross profit12 months2016-01-01 to 2016-12-31$28.86bnus-gaap:GrossProfit
Operating income3 months2016-10-01 to 2016-12-31$3.00bnus-gaap:OperatingIncomeLoss
Operating income12 months2016-01-01 to 2016-12-31$10.34bnus-gaap:OperatingIncomeLoss
Interest expense12 months2016-01-01 to 2016-12-31$1.08bnus-gaap:InterestExpense
Income tax12 months2016-01-01 to 2016-12-31$3.32bnus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-10-01 to 2016-12-31$1.71bnus-gaap:NetIncomeLoss
Net income12 months2016-01-01 to 2016-12-31$5.32bnus-gaap:NetIncomeLoss
Diluted EPS3 months2016-10-01 to 2016-12-31$1.59us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2016-01-01 to 2016-12-31$4.90us-gaap:EarningsPerShareDiluted
Basic EPS3 months2016-10-01 to 2016-12-31$1.60us-gaap:EarningsPerShareBasic
Basic EPS12 months2016-01-01 to 2016-12-31$4.93us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2016-01-01 to 2016-12-311,079,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2016-01-01 to 2016-12-31$10.07bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2016-01-01 to 2016-12-31$2.22bnus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2016-01-01 to 2016-12-31$1.84bnus-gaap:PaymentsOfDividends
Share repurchases12 months2016-01-01 to 2016-12-31$4.46bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2016-12-31$3.37bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-12-31$31.04bnus-gaap:AssetsCurrent
Total assetsAt period end2016-12-31$94.46bnus-gaap:Assets
Current liabilitiesAt period end2016-12-31$26.25bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2016-12-31$25.61bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2016-12-31$42.0mus-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2016-12-31$1.87bnus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2016-12-31$36.83bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000064803-17-000006. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.